CN
135-70-6
应用筛选条件
关键词:'135-70-6'
显示 31-60 共 253 条结果 关于 "135-70-6" 范围 技术文档
Heart dECM Gel Hydrogel Kit
thoroughly by vortexing the mixture.
3. Add 135 µL cell culture media into the ECM/Component mixture from step 2 to yield a final hydrogel concentration
of 6 mg/mL. Mix thoroughly by vortexing. Note: While
Kidney dECM Gel Hydrogel Kit
thoroughly by vortexing the mixture.
3. Add 135 µL cell culture media into the ECM/Component mixture from step 2 to yield a final hydrogel concentration
of 6 mg/mL. Mix thoroughly by vortexing. Note: While
Data Sheet - M1314
P.S., New insights into
the control of cell growth; the role of the Axl family.
Pathology, 29, 131-135 (1997).
3. Lu, Q. and Lemke, G., Homeostatic regulation of
the immune system by receptor tyrosine
MF-Millipore Filters: A biologically inert mixture of cellulose acetate and cellulose nitrate
2.46 2.11 2.32 1.2 0.98 1.12 0.77 0.7 0.42 0.42
50 35 32 28 17 16 16 12 10 8 6
150 150 150 150 150 150 150 150 150 135 135
18 32 60 60 140
Data Sheet - S7073
,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼73 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 99–135 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product
Data Sheet - M1074 - Lot 109K0784
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼135 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 7–11 nmole/min/mg (see Figure 2)
Precautions
Data Sheet - S1201 - Lot 061M0744
0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼135 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 132–182 nmole/min/mg (see Figure 2)
Precautions
Data Sheet - B4062
a 50 ng/µL BSA and 5% glycerol solution.
0
35,000
70,000
105,000
140,000
0 45 90 135 180
Protein (ng)
A
ct
iv
ity
(c
pm
)
Data Sheet - S1201 - Lot 109K0796
0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼135 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 132–182 nmole/min/mg (see Figure 2)
Precautions
Product Information Sheet - M1021
et al., The parkinsonian toxin
MPTP: action and mechanism. Restor. Neurol.
Neurosci., 16(2), 135-142 (2000).
3. Adams, J. D., Jr., et al., Parkinson's disease -
redox mechanisms. Curr. Med
Data Sheet - SRP5279
,
300 mM NaCl, 150 mM imidazole, 0.1 mM PMSF,
0.25 mM DTT, and 25% glycerol.
Molecular mass: ∼135 kDa
Precautions and Disclaimer
This product is for R&D use only, not for drug,
household, or other
Data Sheet - M1074
NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼135 kDa
Precautions and Disclaimer
This product is for R&D use only, not for drug,
household, or other
Data Sheet - A0608
7.0,
300 mM NaCl, 150 mM imidazole, 0.1 mM PMSF,
0.2 mM DTT, and 25% glycerol.
Molecular mass: ∼135 kDa
Precautions and Disclaimer
This product is for R&D use only, not for drug,
household, or other
Data Sheet - A0608 - Lot 031M0726
mM NaCl, 150 mM imidazole, 0.1 mM PMSF,
0.2 mM DTT, and 25% glycerol.
Molecular mass: ∼135 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 717–971 nmole/min/mg (see Figure 2)
Precautions
Data Sheet - A0608 - Lot 041M1004V
mM NaCl, 150 mM imidazole, 0.1 mM PMSF,
0.2 mM DTT, and 25% glycerol.
Molecular mass: ∼135 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 717–971 nmole/min/mg (see Figure 2)
Precautions
Data Sheet - A0608 - Lot 040M0738
mM NaCl, 150 mM imidazole, 0.1 mM PMSF,
0.2 mM DTT, and 25% glycerol.
Molecular mass: ∼135 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 717–971 nmole/min/mg (see Figure 2)
Precautions
Data Sheet - A0608 - Lot 110M0862
mM NaCl, 150 mM imidazole, 0.1 mM PMSF,
0.2 mM DTT, and 25% glycerol.
Molecular mass: ∼135 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 717–971 nmole/min/mg (see Figure 2)
Precautions
Data Sheet - A0608 - Lot SLBB9134V
mM NaCl, 150 mM imidazole, 0.1 mM PMSF,
0.2 mM DTT, and 25% glycerol.
Molecular mass: ∼135 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 717–971 nmole/min/mg (see Figure 2)
Precautions
Data Sheet - A0608 - Lot 019K1603
mM NaCl, 150 mM imidazole, 0.1 mM PMSF,
0.2 mM DTT, and 25% glycerol.
Molecular mass: ∼135 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 717–971 nmole/min/mg (see Figure 2)
Precautions
Data Sheet - A0608 - Lot 041M0987
mM NaCl, 150 mM imidazole, 0.1 mM PMSF,
0.2 mM DTT, and 25% glycerol.
Molecular mass: ∼135 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 717–971 nmole/min/mg (see Figure 2)
Precautions
BIOshell Glycan HPLC Columns
0
10
20
30
40
50
60
70
80
90
100
0 10 20 30 40 50 60 70
Re
la
ti
ve
In
te
ns
it
Bone dECM Gel Hydrogel Kit
thoroughly by vortexing the mixture.
3. Add 135 µL cell culture media into the ECM/Component mixture from step 2 to yield a final hydrogel concentration
of 6 mg/mL. Mix thoroughly by vortexing. Note: While
Absolute Quantifi cation of the Lower Abundance Proteome Through Immunoaffi nity Depletion of the Twenty Most Abundant Proteins in Human Serum
Results
A
20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135
Time (min)
0
1
2
3
Data Sheet - D0315
P.S., New insights into
the control of cell growth; the role of the Axl family.
Pathology, 29, 131-135 (1997).
3. Lu, Q. and Lemke, G., Homeostatic regulation of
the immune system by receptor tyrosine
Data Sheet - D0190
P.S., New insights into
the control of cell growth; the role of the Axl family.
Pathology, 29, 131-135 (1997).
3. Lu, Q. and Lemke, G., Homeostatic regulation of
the immune system by receptor tyrosine
Product Information Sheet - M0896
et al., The parkinsonian toxin
MPTP: action and mechanism. Restor. Neurol.
Neurosci., 16(2), 135-142 (2000).
3. Adams, J. D., Jr., et al., Parkinson's disease -
redox mechanisms. Curr. Med
Data Sheet - T3448
molecular mass of approximately 107.2 kDa. As a result
of glycosylation, the protein migrates to 125-135 kDa in
SDS-PAGE under reducing conditions.
Tie-1/Tie (tyrosine kinase with Ig and EGF homology
BRAF (416-766) Active (B4062)
a 50 ng/µl BSA and 5% glycerol solution.
0
35,000
70,000
105,000
140,000
0 45 90 135 180
Protein (ng)
A
ct
iv
ity
(c
pm
)
BRAF (416-766) Active (B4062)
a 50 ng/µl BSA and 5% glycerol solution.
0
35,000
70,000
105,000
140,000
0 45 90 135 180
Protein (ng)
A
ct
iv
ity
(c
pm
)
Data Sheet - B4062 - Lot SLBB2536V
a 50 ng/µL BSA and 5% glycerol solution.
0
35,000
70,000
105,000
140,000
0 45 90 135 180
Protein (ng)
A
ct
iv
ity
(c
pm
)
2/9